Indira Mendez‐David, Denis Joseph David, Claudine Deloménie, Laurent Tritschler, Jean‐Martin Beaulieu, Romain Colle, Emmanuelle Corruble, Alain Michel Gardier & René Hen. (2023) A complex relation between levels of adult hippocampal neurogenesis and expression of the immature neuron marker doublecortin. Hippocampus 33:10, pages 1075-1093.
Crossref
Raina Ardasheva, Natalia Prissadova, Valentin Turiyski, Anna Tolekova, Athanas Krastev, Mina Pencheva & Veselin Popov. (2023) Effects of Electron Radiation on Serotonin Signaling and Reactivity of Rat Gastric Smooth Muscle. Toxics 11:7, pages 603.
Crossref
Samuel T. Slocum, Jeffrey F. DiBerto & Bryan L. Roth. (2021) Molecular insights into psychedelic drug action. Journal of Neurochemistry 162:1, pages 24-38.
Crossref
A. L. Pehrson, D. Roberts, A. Khawaja & R. McNair. (2022) The role of serotonin neurotransmission in rapid antidepressant actions. Psychopharmacology 239:6, pages 1823-1838.
Crossref
Agnieszka Zagórska, Adam Bucki, Anna Partyka, Magdalena Jastrzębska-Więsek, Agata Siwek, Monika Głuch-Lutwin, Barbara Mordyl, Anna Jaromin, Maria Walczak, Anna Wesołowska & Marcin Kołaczkowski. (2022) Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia. European Journal of Medicinal Chemistry 233, pages 114218.
Crossref
Nikita Deo & Gregory Redpath. (2022) Serotonin Receptor and Transporter Endocytosis Is an Important Factor in the Cellular Basis of Depression and Anxiety. Frontiers in Cellular Neuroscience 15.
Crossref
Terry P. Kenakin. 2022. A Pharmacology Primer. A Pharmacology Primer
151
188
.
Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk & Agnieszka A. Kaczor. (2021) Overcoming Depression with 5-HT2A Receptor Ligands. International Journal of Molecular Sciences 23:1, pages 10.
Crossref
Alizée Arnoux & Estelle Ayme-Dietrich. 2021. 5-HT2B Receptors. 5-HT2B Receptors
213
229
.
Eline Pottie, Peter Dedecker & Christophe P. Stove. (2020) Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays. Biochemical Pharmacology 182, pages 114251.
Crossref
Eric A. Wold, Christopher T. Wild, Kathryn A. Cunningham & Jia Zhou. (2019) Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. Current Topics in Medicinal Chemistry 19:16, pages 1381-1398.
Crossref
Ping Liu, Yu-ling Yin, Ting Wang, Li Hou, Xiao-xi Wang, Man Wang, Guan-guan Zhao, Yi Shi, H. Eric Xu & Yi Jiang. (2019) Ligand-induced activation of ERK1/2 signaling by constitutively active Gs-coupled 5-HT receptors. Acta Pharmacologica Sinica 40:9, pages 1157-1167.
Crossref
Benedetta Assetta, Jenna Morris-Love, Gretchen V. Gee, Abigail L. Atkinson, Bethany A. O’Hara, Melissa S. Maginnis, Sheila A. Haley & Walter J. Atwood. (2019) Genetic and Functional Dissection of the Role of Individual 5-HT2 Receptors as Entry Receptors for JC Polyomavirus. Cell Reports 27:7, pages 1960-1966.e6.
Crossref
Terry P. Kenakin. 2019. A Pharmacology Primer. A Pharmacology Primer
97
132
.
Simin Afshar, Siamak Shahidi, Ali Haeri Rohani, Alireza Komaki & Sara Soleimani Asl. (2018) The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats. Psychopharmacology 235:10, pages 2809-2822.
Crossref
Julia Bräunig, Juliane Dinter, Carolin S. Höfig, Sarah Paisdzior, Michal Szczepek, Patrick Scheerer, Mark Rosowski, Jens Mittag, Gunnar Kleinau & Heike Biebermann. (2018) The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor. Frontiers in Pharmacology 9.
Crossref
Cullen L. Schmid & Laura M. Bohn. 2018. 5-HT2A Receptors in the Central Nervous System. 5-HT2A Receptors in the Central Nervous System
31
55
.
Minal Jaggar & Vidita A. Vaidya. 2018. 5-HT2A Receptors in the Central Nervous System. 5-HT2A Receptors in the Central Nervous System
395
438
.
Imane Moutkine, Emily Quentin, Bruno P. Guiard, Luc Maroteaux & Stephane Doly. (2017) Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. Journal of Biological Chemistry 292:15, pages 6352-6368.
Crossref
Kendra H. Oliver, Matthew T. Duvernay, Heidi E. Hamm & Ana M.D. Carneiro. (2016) Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor. Journal of Biological Chemistry 291:38, pages 20210-20219.
Crossref
Terry Kenakin. (2016) Measurement of Receptor Signaling Bias. Current Protocols in Pharmacology 74:1.
Crossref
David E. Nichols. (2016) Psychedelics. Pharmacological Reviews 68:2, pages 264-355.
Crossref
Benjamin Adam Samuels, Indira Mendez-David, Charlène Faye, Sylvain André David, Kerri A. Pierz, Alain M. Gardier, René Hen & Denis J. David. (2014) Serotonin 1A and Serotonin 4 Receptors. The Neuroscientist 22:1, pages 26-45.
Crossref
Javier Catalán. (2015) Fluorosolvatochromism of monomethyl indoles: further evidence in support of a new photophysical model for the indole chromophore. Journal of Physical Organic Chemistry 28:5, pages 329-336.
Crossref
Javier Catalán. (2015) The first UV absorption band for indole is not due to two simultaneous orthogonal electronic transitions differing in dipole moment. Physical Chemistry Chemical Physics 17:19, pages 12515-12520.
Crossref
Terry Kenakin. 2015. G Protein-Coupled Receptors in Drug Discovery. G Protein-Coupled Receptors in Drug Discovery
163
176
.
Cullen L Schmid, John M Streicher, Herbert Y Meltzer & Laura M Bohn. (2014) Clozapine Acts as an Agonist at Serotonin 2A Receptors to Counter MK-801-Induced Behaviors through a βArrestin2-Independent Activation of Akt. Neuropsychopharmacology 39:8, pages 1902-1913.
Crossref
Terry Kenakin. 2014. Biased Signaling in Physiology, Pharmacology and Therapeutics. Biased Signaling in Physiology, Pharmacology and Therapeutics
81
102
.
Terry P. Kenakin. 2014. A Pharmacology Primer. A Pharmacology Primer
85
117
.
Terry Kenakin. 2014. Arrestins - Pharmacology and Therapeutic Potential. Arrestins - Pharmacology and Therapeutic Potential
57
83
.
Tatiana V Lipina, Paul J Fletcher, Frankie H Lee, Albert HC Wong & John C Roder. (2012) Disrupted-In-Schizophrenia-1 Gln31Leu Polymorphism Results in Social Anhedonia Associated with Monoaminergic Imbalance and Reduction of CREB and β-arrestin-1,2 in the Nucleus Accumbens in a Mouse Model of Depression. Neuropsychopharmacology 38:3, pages 423-436.
Crossref
Camille Latapy & Jean Martin Beaulieu. 2013. The Molecular Biology of Arrestins. The Molecular Biology of Arrestins
267
295
.
José Brea & María Isabel Loza. 2012. Therapeutic Targets. Therapeutic Targets
455
476
.
Yasmine Chabbi-AchengliAmélie E. CoudertJacques Callebert, Valérie Geoffroy, Francine Côté, Corinne Collet & Marie-Christine de Vernejoul. (2012) Decreased osteoclastogenesis in serotonin-deficient mice. Proceedings of the National Academy of Sciences 109:7, pages 2567-2572.
Crossref
Javier Catalán & Juan Pablo Catalán. (2011) Questioning the photophysical model for the indole chromophore in the light of evidence obtained by controlling the non-specific effect of the medium with 1-chlorobutane as solvent. Physical Chemistry Chemical Physics 13:33, pages 15022.
Crossref
Guillermo Romero, Mark von Zastrow & Peter A. Friedman. 2011. Pharmacology of G Protein Coupled Receptors. Pharmacology of G Protein Coupled Receptors
279
314
.